BIO RAD LABORATORIES INC company info

CIK 12208
IRS Number 941381833
State of incorporation DE
Business address 1000 ALFRED NOBEL DRIVE
None
HERCULES
CA
94547
Mail address 1000 ALFRED NOBEL DRIVE
None
HERCULES
CA
94547

Short summary

BIO RAD LABORATORIES INC is a California company, with head office located at 1000 Alfred Nobel Drive Hercules, California 94547. The company achieved a record breaking net income in 2010 - 185.49 million USD. In 2015 the company owned a total of 3.87 billion USD worth of assets, including 1.81 billion USD worth of current assets. The company amassed the most assets last year, totalling up to 3.87 billion USD. The company net sales last year amounted to 2.02 billion USD. The company allocated 192.97 million USD of its income to research and development.

BIO RAD LABORATORIES INC Income Statement

Name [in Millions USD]200720082009201020112012201320142015Trends
Revenue, Net 1,764.371,784.241,927.122,073.532,069.242,132.692,175.042,019.44
Gross Profit 962.52999.841,091.491,177.891,155.161,178.481,178.521,121.67
Selling, General and Administrative Expense 591.30601.47635.21696.29681.78798.07808.20761.99
Research and development 159.52163.59172.27186.44209.20210.95220.33192.97
Operating Income (Loss) 182.94230.99284.01295.16264.18169.46149.98166.71
Interest expense 32.1147.0263.7253.1451.1161.2722.1321.69
Investment Income, Interest and Dividend 5.705.208.2011.4013.4013.5010.10
Other Nonoperating Income (Expense) 0.35-6.873.887.5821.8812.7713.0111.08
Income Tax Expense (Benefit) 44.5836.6733.3557.7464.3634.5742.7132.75
Net income 89.51144.62185.49179.01165.4877.7988.85113.09

BIO RAD LABORATORIES INC Balance Sheet

Name [in Millions USD]200720082009201020112012201320142015Trends
Cash and cash equivalents 161.76533.47614.22670.30456.49367.00384.67450.13418.65
Accounts Receivable, Net, Current 373.82395.97378.89354.16366.28
Inventories 370.27449.34449.46484.67520.64500.98541.51
Deferred income taxes 43.1048.0253.7857.75
Property, Plant and Equipment, Gross 728.15875.13937.721,032.391,130.391,109.121,179.11
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -425.73526.69557.07613.86690.06669.48721.42
Goodwill 329.39393.13466.16501.50535.22514.08505.31
Intangible Assets, Net (Excluding Goodwill) 292.55237.71230.71
Total assets 2,527.123,044.253,168.903,482.823,467.753,525.343,874.64
Current assets 1,555.831,889.661,811.071,903.041,767.491,741.931,805.69
Accounts payable 120.51119.45129.12125.46128.61122.39
Taxes Payable, Current 49.3732.6125.9032.6025.2421.86
Standard Product Warranty Accrual 1816.40
Total current liabilities 389.50442.84417.18431.24480.25403.89410.41
Long-term Debt, Excluding Current Maturities 734.34731.33732.05732.80435.61
Long-term Debt 294.80732732.50733435.80
Deferred income taxes 42.8959.7485.52115.05162.11211.96233.48
Total liabilities 1,224.391,318.331,316.401,411.881,217.811,166.451,260.07
Common Stock, Value, Issued 0.000.00
Retained Earnings (Accumulated Deficit) 1,069.021,254.771,439.261,577.861,644.421,741.201,838.35
Accumulated Other Comprehensive Income (Loss), Net of Tax 75.38296.57214.24267.39351.29332.05459.56

BIO RAD LABORATORIES INC Cash Flow

Name [in Millions USD]200720082009201020112012201320142015Trends
Net income 89.51144.62185.49179.01165.4877.7988.85113.09
Amortization of Intangible Assets 33.7039.1042.804547.8036.50
Depreciation and amortization 101.70108.90121130.40147.20149.90131.80
Deferred Income Tax Expense (Benefit) -11.70-4.10-2-10.30-4.70-6-6.10
Accounts receivable -4.303720.10-4.4024.20-11.1039
Inventories -35.8015.9045.204.3033.40-5.8054.20
Net Cash Provided by (Used in) Operating Activities 191.37325.07225.91262.74266.48175.48273.31186.20
Payments to Acquire Property, Plant, and Equipment 68.0488.45102.89152.42113.00121.00112
Payments to Acquire Productive Assets -84.81-66.80-87.26
Payments to Acquire Intangible Assets -4-9.574.080.441.780.7015.481.37
Net Cash Provided by (Used in) Investing Activities -146.11-175.95-216.51-386.33-409.93-5.42-190.51-166.87
Proceeds from Issuance of Long-term Debt 1.60294.75424.6300
Proceeds from Issuance of Common Stock 12.9110.2912.7314.2510.6111.2415.058.24
Payments for Repurchase of Common Stock 000.1000
Net Cash Provided by (Used in) Financing Activities 6.33293.93228.75-213.5612.59-311.7011.698.58
Cash and Cash Equivalents, Period Increase (Decrease) 42.76445.41256.61-332.32-110.84-131.8481.7044.30